{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:21:31Z","timestamp":1791908491944,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T00:00:00Z","timestamp":1750550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.radonc.2025.111000","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T11:04:31Z","timestamp":1750503871000},"page":"111000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Neuroprotection in radiotherapy of brain metastases \u2013 a European pattern-of-care analysis by the ESTRO CNS Focus group"],"prefix":"10.1016","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0671-9003","authenticated-orcid":false,"given":"N.","family":"Gleim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0993-1288","authenticated-orcid":false,"given":"A.","family":"Turcas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Minniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2255-2255","authenticated-orcid":false,"given":"A.L.","family":"Grosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7288-8975","authenticated-orcid":false,"given":"T.","family":"Kazda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1785-3184","authenticated-orcid":false,"given":"M.","family":"Harat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1510-7500","authenticated-orcid":false,"given":"S.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Niyazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2550-1410","authenticated-orcid":false,"given":"N.H.","family":"Nicolay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8178-5089","authenticated-orcid":false,"given":"C.","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.111000_b0005","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/neuonc\/noab101","article-title":"Epidemiology of brain metastases and leptomeningeal disease","volume":"23","author":"Lamba","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.radonc.2025.111000_b0010","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.21037\/atm-21-3665","article-title":"Brain metastases: increasingly precision medicine-a narrative review","volume":"9","author":"McKay","year":"2021","journal-title":"Annals Transl Med"},{"key":"10.1016\/j.radonc.2025.111000_b0015","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1200\/JCO.20.01255","article-title":"Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient","volume":"38","author":"Sperduto","year":"2020","journal-title":"J ClinOncol."},{"key":"10.1016\/j.radonc.2025.111000_b0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12094-022-02927-3","article-title":"The correlations between psychological distress, cognitive impairment and quality of life in patients with brain metastases after whole-brain radiotherapy","volume":"25","author":"Yao","year":"2023","journal-title":"Clin & Transl Oncol: Offi Publ Federat Spanish Oncol Soc Natl Cancer Inst Mexico"},{"key":"10.1016\/j.radonc.2025.111000_b0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.adro.2019.07.012","article-title":"Radiation therapy practice patterns for brain metastases in the united states in the stereotactic radiosurgery era","volume":"5","author":"Barbour","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111000_b0030","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","article-title":"EANO-ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours","volume":"32","author":"Le Rhun","year":"2021","journal-title":"Annals Oncol: Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.radonc.2025.111000_b0035","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","article-title":"Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study","volume":"15","author":"Yamamoto","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.radonc.2025.111000_b0040","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.ijrobp.2020.07.2108","article-title":"Stereotactic radiosurgery versus whole-brain radiation therapy for patients with 4-15 brain metastases: a phase III randomized controlled trial","volume":"108","author":"Li","year":"2020","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"10.1016\/j.radonc.2025.111000_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109744","article-title":"Stereotactic radiosurgery versus whole-brain radiotherapy in patients with 4-10 brain metastases: a nonrandomized controlled trial","volume":"186","author":"Bodensohn","year":"2023","journal-title":"Radiothe Oncol: J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2025.111000_b0050","article-title":"Stereotactic radiosurgery for 1-10 brain metastases to avoid whole-brain radiotherapy - results of the CYBER-SPACE randomized phase 2 trial","author":"El Shafie","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2025.111000_b0055","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11060-023-04358-8","article-title":"Retrospective non-inferiority study of stereotactic radiosurgery for more than ten brain metastases","volume":"163","author":"Nagai","year":"2023","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2025.111000_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15123193","article-title":"PRO: do we still need Whole-brain irradiation for brain metastases?","volume":"15","author":"Popp","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2025.111000_b0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.semradonc.2023.01.005","article-title":"Brain metastases: is there still a role for whole-brain radiation therapy?","volume":"33","author":"Nieder","year":"2023","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.radonc.2025.111000_b0070","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1200\/JCO.2017.75.9589","article-title":"Whole-brain radiotherapy for brain metastases: evolution or revolution?","volume":"36","author":"Brown","year":"2018","journal-title":"J ClinOncol."},{"key":"10.1016\/j.radonc.2025.111000_b0075","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1200\/JCO.2014.57.2909","article-title":"Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial","volume":"32","author":"Gondi","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111000_b0080","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1200\/JCO.19.02767","article-title":"Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001","volume":"38","author":"Brown","year":"2020","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111000_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2023.04.030","article-title":"Sustained preservation of cognition and prevention of patient-reported symptoms with hippocampal avoidance during whole-brain radiotherapy for brain metastases: final results of NRG oncology CC001","author":"Gondi","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111000_b0090","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/neuonc\/noaa092","article-title":"Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer","volume":"22","author":"Westover","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.radonc.2025.111000_b0095","doi-asserted-by":"crossref","first-page":"50986","DOI":"10.18632\/oncotarget.9653","article-title":"A pilot study using dynamic contrast enhanced-MRI as a response biomarker of the radioprotective effect of memantine in patients receiving whole brain radiotherapy","volume":"7","author":"Wong","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2025.111000_b0100","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/neuonc\/nox203","article-title":"Memantine prevents acute radiation-induced toxicities at hippocampal excitatory synapses","volume":"20","author":"Duman","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.radonc.2025.111000_b0105","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/neuonc\/not114","article-title":"Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Brown","year":"2013","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.radonc.2025.111000_b0110","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1200\/JCO.20.00747","article-title":"Hippocampal avoidance and memantine for whole-brain radiotherapy: long-term follow-up warranted","volume":"38","author":"Andratschke","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111000_b0115","article-title":"Mitigating radiation-induced cognitive toxicity in brain metastases: more questions than answers","volume":"6","author":"Sim\u00f3","year":"2024","journal-title":"Neuro-Oncol Adv"},{"key":"10.1016\/j.radonc.2025.111000_b0120","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.6004\/jnccn.2020.0052","article-title":"Central nervous System cancers, version 3.2020 NCCN clinical practice guidelines oncology","volume":"18","author":"Nabors","year":"2020","journal-title":"Journal of the National Comprehensive Cancer Network : JNCCN"},{"key":"10.1016\/j.radonc.2025.111000_b0125","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO Guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"JCO"},{"key":"10.1016\/j.radonc.2025.111000_b0130","unstructured":"R Core Team (2023) R: A Language and Environment for Statistical Computing. https:\/\/www.R-project.org\/."},{"key":"10.1016\/j.radonc.2025.111000_b0135","article-title":"ESTRO guidelines for developing questionnaires in survey-based radiation oncology research","volume":"51","author":"Webster","year":"2025","journal-title":"ctRO"},{"key":"10.1016\/j.radonc.2025.111000_b0140","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cct.2015.12.013","article-title":"The impact of RTOG 0614 and RTOG 0933 trials in routine clinical practice: the US survey of utilization of Memantine and IMRT planning for hippocampus sparing in patients receiving whole brain radiotherapy for brain metastases","volume":"47","author":"Slade","year":"2016","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.radonc.2025.111000_b0145","doi-asserted-by":"crossref","first-page":"89","DOI":"10.12788\/jcso.0305","article-title":"Patterns of care with regard to whole-brain radiotherapy technique and delivery among academic centers in the United States","volume":"15","author":"Barry","year":"2017","journal-title":"J Community Support Oncol"},{"key":"10.1016\/j.radonc.2025.111000_b0150","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11060-020-03542-4","article-title":"Prescription of memantine during non-stereotactic, brain-directed radiation among patients with brain metastases: a population-based study","volume":"148","author":"Lamba","year":"2020","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2025.111000_b0155","article-title":"Practice patterns related to mitigation of neurocognitive decline in patients receiving whole brain radiation therapy","volume":"7","author":"Jairam","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111000_b0160","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11060-021-03714-w","article-title":"Management of multiple brain metastases: a patterns of care survey within the German Society for Radiation Oncology","volume":"152","author":"Kraft","year":"2021","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2025.111000_b0165","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00066-022-01991-6","article-title":"Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO)","volume":"198","author":"Rogers","year":"2022","journal-title":"Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft [et al]"},{"key":"10.1016\/j.radonc.2025.111000_b0170","article-title":"Neuroprotection in radiotherapy of brain metastases: a pattern-of-care analysis in Germany, Austria and Switzerland by the German Society for radiation Oncology - working group Neuro-Radio-Oncology (DEGRO AG-NRO)","volume":"47","author":"Gleim","year":"2024","journal-title":"Clin Trans Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111000_b0175","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/neuros\/nyy216","article-title":"Does stereotactic radiosurgery have a role in the management of patients presenting with 4 or more brain metastases?","volume":"84","author":"Soike","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.radonc.2025.111000_b0180","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1186\/s12885-023-11452-7","article-title":"Overall survival following stereotactic radiosurgery for ten or more brain metastases: a systematic review and meta-analysis","volume":"23","author":"Rozati","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2025.111000_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16091742","article-title":"Long-term results of stereotactic radiotherapy in patients with at least 10 brain metastases at diagnosis","volume":"16","author":"Kinj","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2025.111000_b0190","article-title":"Safety and feasibility of stereotactic radiosurgery for patients with 15 or more brain metastases","volume":"9","author":"Upadhyay","year":"2024","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.radonc.2025.111000_b0195","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1227\/neu.0000000000002482","article-title":"Single-session Gamma Knife radiosurgery for patients with 20 or more brain metastases","volume":"93","author":"Wei","year":"2023","journal-title":"Neurosurgery"},{"key":"10.1016\/j.radonc.2025.111000_b0200","doi-asserted-by":"crossref","DOI":"10.21037\/apm-23-448","article-title":"Palliative whole brain radiation therapy: an international state of practice","author":"Keit","year":"2023","journal-title":"Annals of Palliative Med"},{"key":"10.1016\/j.radonc.2025.111000_b0205","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1186\/s12885-020-07011-z","article-title":"Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG)","volume":"20","author":"Grosu","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2025.111000_b0210","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.21873\/anticanres.16482","article-title":"Whole-brain radiotherapy with or without a simultaneous integrated boost for treatment of brain metastases","volume":"43","author":"Rades","year":"2023","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2025.111000_b0215","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.7150\/jca.95804","article-title":"Efficacy of whole-brain radiotherapy plus simultaneous integrated boost (SIB-WBRT) for lung cancer brain metastases","volume":"15","author":"Bi","year":"2024","journal-title":"J Cancer"},{"key":"10.1016\/j.radonc.2025.111000_b0220","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1002\/cncr.32787","article-title":"Hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for multiple brain metastases","volume":"126","author":"Popp","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2025.111000_b0225","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1186\/s12885-023-11286-3","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2025.111000_b0230","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1186\/s12885-024-12559-1","article-title":"Hippocampal avoidance whole-brain radiotherapy with simultaneous integrated boost in lung cancer brain metastases and utility of the Hopkins verbal learning test for testing cognitive impairment in chinese patients: a prospective phase II study","volume":"24","author":"Li","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2025.111000_b0235","article-title":"Patterns of care for brain metastases in asia: a real-world survey conducted by the federation of asian organizations for radiation oncology","volume":"10","author":"Uchinami","year":"2024","journal-title":"JCO global oncology"},{"key":"10.1016\/j.radonc.2025.111000_b0240","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1200\/JCO.21.00639","article-title":"Randomized phase III trial of prophylactic cranial irradiation with or without hippocampal avoidance for small-cell lung cancer (PREMER): a GICOR-GOECP-SEOR Study","volume":"39","author":"Rodr\u00edguez de Dios","year":"2021","journal-title":"J ClinOncol."},{"key":"10.1016\/j.radonc.2025.111000_b0245","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jtho.2020.12.024","article-title":"Phase 3 Randomized trial of prophylactic cranial irradiation with or without hippocampus avoidance in SCLC (NCT01780675)","volume":"16","author":"Belderbos","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.radonc.2025.111000_b0250","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1298605","article-title":"Unilateral hippocampal sparing during whole brain radiotherapy for multiple brain metastases: narrative and critical review","volume":"14","author":"Pospisil","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.111000_b0255","article-title":"Cost of treatment for brain metastases using data from a national health insurance","volume":"9","author":"Crooks","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111000_b0260","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/nop\/npac093","article-title":"Cost-effectiveness analysis of 3 radiation treatment strategies for patients with multiple brain metastases","volume":"10","author":"Chen","year":"2023","journal-title":"Neuro-Oncol Pract"},{"key":"10.1016\/j.radonc.2025.111000_b0265","article-title":"Advancing beyond the hippocampus to preserve cognition for patients with brain metastases: dosimetric results from a phase 2 trial of memory-avoidance whole brain radiation therapy","volume":"9","author":"Perlow","year":"2024","journal-title":"Adv Radiat Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025045049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025045049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:22:59Z","timestamp":1761128579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025045049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":53,"alternative-id":["S0167814025045049"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111000","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotection in radiotherapy of brain metastases \u2013 a European pattern-of-care analysis by the ESTRO CNS Focus group","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111000","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111000"}}